°³¿ä
À̺¥Æ® °³¿ä
À̺¥Æ® Ư¡
Âü°¡ÀÚ
¾ÆÁ¨´Ù
ÄÁÆÛ·±½º ÇÁ·Î±×·¥
½ÉÆ÷Áö¾ö
Æ®·¹ÀÌ´× ¼¼¹Ì³ª
±âÁ¶ °¿¬
¹öÁî ¼¼¼Ç
¿¬»ç
½ºÆù¼ / Àü½Ã±â¾÷
½ºÆù¼
Àü½Ã±â¾÷ Ç÷ξîÇ÷£
°³ÃÖÁö
Æ÷½ºÅÍ
¹Ìµð¾î
¹®ÀÇ
Âü°¡½Åû
¹ÙÀÌ¿ÀÀǾàǰ ¹ß°ß°ú °³¹ßÀÇ Áß°³
1¿ù 13ÀÏ ½ÉÆ÷Áö¾ö
1¿ù 14 - 15ÀÏ
1¿ù 15 - 16ÀÏ
1¿ù 13ÀÏ ½ÉÆ÷Áö¾ö
PROTEIN EXPRESSION
´Ü¹éÁú ¹ßÇö
HIGHER THROUGHPUT
ÇÏÀ̽º·çDzÈ
DEVELOPABILITY AND CHARACTERIZATION
°³¹ß °¡´É¼º°ú Ư¼º Æò°¡
NEW
TARGETED THERAPIES
Ç¥ÀûÄ¡·á
ANTIBODY ENGINEERING
Ç×ü ¿£Áö´Ï¾î¸µ
(Re)Discovering Expression Platforms
¹ßÇö Ç÷§ÆûÀÇ (Àç)¹ß°ß
Predictive Protein Production
´Ü¹éÁú »ý»ê ¿¹Ãø
ML and Predictive Methods
ML°ú ¿¹Ãø ¹æ¹ý
Vectors for Targeted Delivery
Ç¥Àû µô¸®¹ö¸®¿ë º¤ÅÍ
Bispecific Engineering & Therapeutics
ÀÌÁ߯¯À̼º ¿£Áö´Ï¾î¸µ°ú ÀǾà
1¿ù 14 - 15ÀÏ
PROTEIN EXPRESSION
´Ü¹éÁú ¹ßÇö
HIGHER THROUGHPUT
ÇÏÀ̽º·çDzÈ
DEVELOPABILITY AND CHARACTERIZATION
°³¹ß °¡´É¼º°ú Ư¼º Æò°¡
NEW
TARGETED THERAPIES
Ç¥ÀûÄ¡·á
ANTIBODY ENGINEERING
Ç×ü ¿£Áö´Ï¾î¸µ
Recombinant Protein Production Part 1
ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê ÆÄÆ® 1
Automation in Protein Sciences
´Ü¹éÁú °úÇп¡¼ÀÇ ÀÚµ¿È
Methods for Developability Analysis
°³¹ß °¡´É¼º ºÐ¼®ÀÇ ¹æ¹ý
Targeted Radioligand Therapies
Ç¥Àû ¹æ»ç¼º ¸®°£µå ¿ä¹ý
Training Seminar
Antibody Engineering
Æ®·¹ÀÌ´× ¼¼¹Ì³ª : Ç×ü ¿£Áö´Ï¾î¸µ
1¿ù 15 - 16ÀÏ
PROTEIN EXPRESSION
´Ü¹éÁú ¹ßÇö
HIGHER THROUGHPUT
ÇÏÀ̽º·çDzÈ
DEVELOPABILITY AND CHARACTERIZATION
°³¹ß °¡´É¼º°ú Ư¼º Æò°¡
NEW
TARGETED THERAPIES
Ç¥ÀûÄ¡·á
ANTIBODY ENGINEERING
Ç×ü ¿£Áö´Ï¾î¸µ
Recombinant Protein Production Part 2
ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê ÆÄÆ® 2
Purification and Quality Assurance
Á¤Á¦¿Í ǰÁú º¸Áõ
Characterization for Novel Biotherapeutics
½Å±Ô ¹ÙÀÌ¿ÀÀǾàǰÀÇ Æ¯¼º Æò°¡
Next-Generation Protein Degradation
Â÷¼¼´ë ´Ü¹éÁú ºÐÇØ
Training Seminar
Antibody Drug Discovery
Æ®·¹ÀÌ´× ¼¼¹Ì³ª : Ç×ü ÀǾàǰ ¹ß°ß
Catalog Download